Table of Contents Author Guidelines Submit a Manuscript
Journal of Transplantation
Volume 2009 (2009), Article ID 379082, 5 pages
http://dx.doi.org/10.1155/2009/379082
Clinical Study

FGF-23 Levels before and after Renal Transplantation

University Department of Nephrology, Hippokration General Hospital, 54642 Thessaloniki, Greece

Received 3 February 2009; Accepted 26 April 2009

Academic Editor: Bruce Kaplan

Copyright © 2009 Domniki Economidou et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. Shimada, H. Hasegawa, Y. Yamazaki et al., “FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis,” Journal of Bone and Mineral Research, vol. 19, no. 3, pp. 429–435, 2004. View at Publisher · View at Google Scholar · View at PubMed
  2. M. Fukagawa, T. Nii-Kono, and J. J. Kazama, “Role of fibroblast growth factor 23 in health and in chronic kidney disease,” Current Opinion in Nephrology and Hypertension, vol. 14, no. 4, pp. 325–329, 2005. View at Publisher · View at Google Scholar
  3. I. Bhan, A. Shah, J. Holmes et al., “Post-transplant hypophosphatemia: tertiary ‘Hyper-Phosphatoninism’?,” Kidney International, vol. 70, no. 8, pp. 1486–1494, 2006. View at Publisher · View at Google Scholar · View at PubMed
  4. P. Evenepoel, M. Naesens, K. Claes, D. Kuypers, and Y. Vanrenterghem, “Tertiary ‘hyperphosphatoninism’ accentuates hypophosphatemia and suppresses calcitriol levels in renal transplant recipients,” American Journal of Transplantation, vol. 7, no. 5, pp. 1193–1200, 2007. View at Publisher · View at Google Scholar · View at PubMed
  5. S. Pande, C. S. Ritter, M. Rothstein et al., “FGF-23 and sFRP-4 in chronic kidney disease and post-renal transplantation,” Nephron Physiology, vol. 104, no. 1, pp. p23–p32, 2006. View at Publisher · View at Google Scholar · View at PubMed
  6. P. Evenepoel, M. Bjorn, M. Naesens et al., “Mineral metabolism and renal phosphate handling in renal transplant recipients and patients with chronic kidney disease matched for eGFR [abstract],” Journal of the American Society of Nephrology, vol. 18, p. 749A, 2007. View at Google Scholar
  7. R. J. Walton and O. L. M. Bijvoet, “Nomogram for derivation of renal threshold phosphate concentration,” The Lancet, vol. 306, no. 7929, pp. 309–310, 1975. View at Publisher · View at Google Scholar
  8. F. Saji, K. Shiizaki, S. Shimada et al., “Regulation of fibroblast growth factor 23 production in bone in uremic rats,” Nephron Physiology, vol. 111, no. 4, pp. 59–66, 2009. View at Google Scholar
  9. M. Mirams, B. G. Robinson, R. S. Mason, and A. E. Nelson, “Bone as a source of FGF23: regulation by phosphate?,” Bone, vol. 35, no. 5, pp. 1192–1199, 2004. View at Publisher · View at Google Scholar · View at PubMed
  10. D. Krocker, C. Perka, J. Tuischer et al., “Effects of tacrolimus, cyclosporin A and sirolimus on MG63 cells,” Transplant International, vol. 19, no. 7, pp. 563–569, 2006. View at Publisher · View at Google Scholar · View at PubMed
  11. A. Torres, V. Lorenzo, and E. Salido, “Calcium metabolism and skeletal problems after transplantation,” Journal of the American Society of Nephrology, vol. 13, no. 2, pp. 551–558, 2002. View at Google Scholar
  12. H. Ghanekar, B. J. Welch, O. W. Moe, and K. Sakhaee, “Post-renal transplantation hypophosphatemia: a review and novel insights,” Current Opinion in Nephrology and Hypertension, vol. 15, no. 2, pp. 97–104, 2006. View at Publisher · View at Google Scholar · View at PubMed